Patents

- Patent Name ESTROBAL
- No. of Patent 10-2769155
- Start Date 20250212
- Patent Description Product Name: ESTROBAL® Pomegranate Extract Origin: Korea (Raw Material: Uzbekistan) Recommended Daily Dosage: 150–500 mg/day Key Features: A patented, K-FDA-approved functional ingredient containing three types of natural estrogens. Clinically proven to alleviate symptoms related to estrogen deficiency in menopausal women. Triple-action: Skin Health +Ovarian & Uterine Health + menopausal symptom relief

Send an Inquiry to this supplier

Send an Inquiry to this supplier
* From
To	김수동 Tina Biotech Inc.
* Subject
* Message	Use English only Max. 2000 characters. (Min. 20) Send
EC21.com does not guarantee the validity of product information or the credentials of sellers.